These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17584025)

  • 21. COX-2 expression in fibroblast aggregates as a functional indicator for the anti-inflammatory activity of leukemia patients' bone marrow-derived hematopoietic cells.
    Egyudova K; Fajtova M; Cizmar A; Korhonen M; Gyarfas J; Kankuri E; Bizik J
    Neoplasma; 2012; 59(5):574-83. PubMed ID: 22668024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recent research advance on bone marrow microenvironment-mediated leukemia drug resistant mechanism].
    Fu B; Ling YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):848-50. PubMed ID: 21729586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping and targeting of the leukemic microenvironment.
    Witkowski MT; Kousteni S; Aifantis I
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31873722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Targeting of the Leukaemia Microenvironment.
    Kuek V; Hughes AM; Kotecha RS; Cheung LC
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular vesicles in hematological malignancies.
    Litwińska Z; Łuczkowska K; Machaliński B
    Leuk Lymphoma; 2019 Jan; 60(1):29-36. PubMed ID: 29745272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of resistance and therapeutic prospect of leukemia mediated by signaling pathway in bone marrow microenvironment.
    Zhang LP; Zhang MY; Liu WJ
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6419-6428. PubMed ID: 31378880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinases in bone marrow: roles of gelatinases in physiological hematopoiesis and hematopoietic malignancies.
    Yu XF; Han ZC
    Histol Histopathol; 2006 May; 21(5):519-31. PubMed ID: 16493582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy.
    Tsiftsoglou AS; Bonovolias ID; Tsiftsoglou SA
    Pharmacol Ther; 2009 Jun; 122(3):264-80. PubMed ID: 19306896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concise Review: Adaptation of the Bone Marrow Stroma in Hematopoietic Malignancies: Current Concepts and Models.
    Doron B; Handu M; Kurre P
    Stem Cells; 2018 Mar; 36(3):304-312. PubMed ID: 29235199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?
    Tavor S; Petit I
    Semin Cancer Biol; 2010 Jun; 20(3):178-85. PubMed ID: 20637871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline mutations in the bone marrow microenvironment and dysregulated hematopoiesis.
    Miller LH; Qu CK; Pauly M
    Exp Hematol; 2018 Oct; 66():17-26. PubMed ID: 30076950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of microenvironment and immunity in drug response in leukemia.
    Bakker E; Qattan M; Mutti L; Demonacos C; Krstic-Demonacos M
    Biochim Biophys Acta; 2016 Mar; 1863(3):414-426. PubMed ID: 26255027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renin expression in hematological malignancies and its role in the regulation of hematopoiesis.
    Teresa Gomez Casares M; de la Iglesia S; Perera M; Lemes A; Campo C; Gonzalez San Miguel JD; Bosch JM; Suarez A; Guerra L; Rodriguez-Peréz JC; Molero T
    Leuk Lymphoma; 2002 Dec; 43(12):2377-81. PubMed ID: 12613527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Vascular Permeability in the Bone Marrow Microenvironment Contributes to Disease Progression and Drug Response in Acute Myeloid Leukemia.
    Passaro D; Di Tullio A; Abarrategi A; Rouault-Pierre K; Foster K; Ariza-McNaughton L; Montaner B; Chakravarty P; Bhaw L; Diana G; Lassailly F; Gribben J; Bonnet D
    Cancer Cell; 2017 Sep; 32(3):324-341.e6. PubMed ID: 28870739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interplay of leukemia cells and the bone marrow microenvironment.
    Duarte D; Hawkins ED; Lo Celso C
    Blood; 2018 Apr; 131(14):1507-1511. PubMed ID: 29487069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic regulation of the bone marrow microenvironment in leukemia.
    Xu B; Hu R; Liang Z; Chen T; Chen J; Hu Y; Jiang Y; Li Y
    Blood Rev; 2021 Jul; 48():100786. PubMed ID: 33353770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenesis in Liquid Tumors: An In Vitro Assay for Leukemic-Cell-Induced Bone Marrow Angiogenesis.
    Zheng Y; Sun Y; Yu X; Shao Y; Zhang P; Dai G; Fu J
    Adv Healthc Mater; 2016 May; 5(9):1014-24. PubMed ID: 26924785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stem cell regulatory niches and their role in normal and malignant hematopoiesis.
    Carlesso N; Cardoso AA
    Curr Opin Hematol; 2010 Jul; 17(4):281-6. PubMed ID: 20473160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phytochemical Modulation of Apoptosis and Autophagy: Strategies to Overcome Chemoresistance in Leukemic Stem Cells in the Bone Marrow Microenvironment.
    Owen HC; Appiah S; Hasan N; Ghali L; Elayat G; Bell C
    Int Rev Neurobiol; 2017; 135():249-278. PubMed ID: 28807161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukemia-stimulated bone marrow endothelium promotes leukemia cell survival.
    Veiga JP; Costa LF; Sallan SE; Nadler LM; Cardoso AA
    Exp Hematol; 2006 May; 34(5):610-21. PubMed ID: 16647567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.